Evidence map›Paper›PMID 33685073›Full record

ArticleJournal of clinical research in pediatric endocrinology2022

The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in

Hakan Döneray, Ayşe Özden, Kadri Gürbüz

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of clinical research in pediatric endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Calcinosis in dermatomyositis: Origins and possible therapeutic avenues.Best practice & research. Clinical rheumatology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hakan DönerayAtatürk University Faculty of Medicine, Department of Pediatric Endocrinology, Erzurum, TurkeyORCID 0000-0002-9774-3649
Ayşe ÖzdenAtatürk University Faculty of Medicine, Department of Pediatric Endocrinology, Erzurum, TurkeyORCID 0000-0002-3625-2387
Kadri GürbüzAtatürk University Faculty of Medicine, Department of Pediatrics, Erzurum, TurkeyORCID 0000-0001-8535-3558
Atatürk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disorder. Topical sodium thiosulfate (STS) and acetazolamide can be a safe and effective treatment for patients who do not respond to conventional therapy for ectopic calcifications. We report the successful treatment of deep soft-tissue calcifications with topical STS and acetazolamide in a boy diagnosed with HFTC due to a novel homozygous mutation of

Indexed as

AcetazolamideHyperostosis, Cortical, CongenitalThiosulfatesCalcinosisFibroblast Growth Factor-23Fibroblast Growth FactorsHumansHyperphosphatemiaMaleMutationAcetazolamideFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth Factorssodium thiosulfateThiosulfatesacetazolamidechildrenHyperphosphatemic familial tumoral calcinosissodium thiosulphatetumoral calcinosis

Identifiers

PMID33685073
PMCPMC9176085
OpenAlexW3133694833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.